Picture of Egetis Therapeutics AB (publ) logo

EGTX Egetis Therapeutics AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Egetis Receives Positive Opinion From European Medicines Agency

July 13 (Reuters) - Egetis Therapeutics AB (publ)  EGTX.ST :
    * RECEIVES POSITIVE OPINION ON ORPHAN DESIGNATION FOR
ALADOTE FROM
THE EUROPEAN MEDICINES AGENCY FOR THE PREVENTION OF ACUTE LIVER
FAILURE

Source text for Eikon:  ID:nMFN8kXNbY 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Egetis Therapeutics AB (publ)

See all news